1-11 of 11
Vanessa Bolejack
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)

Brief Report
Jeffrey A. Zonder, John Crowley, Mohamad A. Hussein, Vanessa Bolejack, Dennis F. Moore, Sr, Brock F. Whittenberger, Muneer H. Abidi, Brian G. M. Durie, Bart Barlogie
Journal: Blood
Blood (2010) 116 (26): 5838–5841.
https://doi.org/10.1182/blood-2010-08-303487
Published: 2010
Includes: Supplemental data
Journal Articles

Predicting Disease Progression to Multiple Myeloma (MM) From MGUS/SMM In SWOG-0120 Observational Trial

Madhav Dhodapkar, MD, MBBS, John Shaughnessy, Jr, PhD, Antje Hoering, PhD, Bijay Nair, MD, MPH, Vanessa Bolejack, Frits van Rhee, MD, PhD, John Crowley, PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1932.
https://doi.org/10.1182/blood.V116.21.1932.1932
Published: 2010
Journal Articles

Modeling for Cure with Total Therapy (TT) Trials for Newly Diagnosed Multiple Myeloma (MM): Let the Math Speak.

Bart Barlogie, MD, PhD, John D Shaughnessy, Jr., Elias Anaissie, MD, PhD, Frits van Rhee, MD, PhD, Yazan Alsayed, MD, PhD, Sarah Waheed, MD, Bijay Nair, MD, Monica Grazziutti, PhD, Vanessa Bolejack, PhD, John Crowley, PhD
Journal: Blood
Blood (2009) 114 (22): 744.
https://doi.org/10.1182/blood.V114.22.744.744
Published: 2009
Journal Articles

Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group

Clinical Trials & Observations
Heinz Ludwig, Brian G. M. Durie, Vanessa Bolejack, Ingemar Turesson, Robert A. Kyle, Joan Blade, Rafael Fonseca, Meletios Dimopoulos, Kazuyuki Shimizu, Jesus San Miguel, Jan Westin, Jean-Luc Harousseau, Meral Beksac, Mario Boccadoro, Antonio Palumbo, Bart Barlogie, Chaim Shustik, Michele Cavo, Philip R. Greipp, Douglas Joshua, Michel Attal, Pieter Sonneveld, John Crowley
Journal: Blood
Blood (2008) 111 (8): 4039–4047.
https://doi.org/10.1182/blood-2007-03-081018
Published: 2008
Includes: Supplemental data
Journal Articles

Denileukin Diftitox (ONTAK) Plus CHOP Chemotherapy in Patients with Peripheral T-Cell Lymphomas (PTCL), the CONCEPT Trial.

Francine Foss, MD, Nelida Sjak-Shie, MD, PhD, Andre Goy, MD, Eric Jacobsen, MD, Ranjana Advani, MD, Mitchell Smith, MD, PhD, Rami Komrokji, MD, Kelly Pendergrass, MD, Vanessa Bolejack, MPH, Karen Watts, Mark Acosta, PharmD
Journal: Blood
Blood (2007) 110 (11): 3449.
https://doi.org/10.1182/blood.V110.11.3449.3449
Published: 2007
Journal Articles

Superiority of Lenalidomide (Len) Plus High-Dose Dexamethasone (HD) Compared to HD Alone as Treatment of Newly-Diagnosed Multiple Myeloma (NDMM): Results of the Randomized, Double-Blinded, Placebo-Controlled SWOG Trial S0232.

Jeffrey A. Zonder, MD, John Crowley, Ph.D., Mohamad A. Hussein, M.D., Vanessa Bolejack, Ph.D, Dennis F. Moore, Sr.M.D., Brock F. Whittenberger, M.D., Muneer H. Abidi, M.D., Brian G.M. Durie, M.D., Bart Barlogie, M.D.
Journal: Blood
Blood (2007) 110 (11): 77.
https://doi.org/10.1182/blood.V110.11.77.77
Published: 2007
Journal Articles

High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis

Clinical Trials & Observations
Frits van Rhee, Vanessa Bolejack, Klaus Hollmig, Mauricio Pineda-Roman, Elias Anaissie, Joshua Epstein, John D. Shaughnessy, Jr, Maurizio Zangari, Guido Tricot, Abid Mohiuddin, Yazan Alsayed, Gail Woods, John Crowley, Bart Barlogie
Journal: Blood
Blood (2007) 110 (3): 827–832.
https://doi.org/10.1182/blood-2007-01-067728
Published: 2007
Journal Articles

Total Therapies (TT) for Newly Diagnosed Patients with Multiple Myeloma (MM): Significant Benefit in High-Risk Disease with Cytogenetic Abnormalities (CA) over the Course of 17 Years.

Frits van Rhee, Vanessa Bolejack, Elias Anaissie, Guido Tricot, Klaus Hollmig, Maurizio Zangari, Mauricio Pineda-Roman, Abid Mohiuddin, Antje Hoering, John Crowley, Bart Barlogie
Journal: Blood
Blood (2006) 108 (11): 3490.
https://doi.org/10.1182/blood.V108.11.3490.3490
Published: 2006
Journal Articles

Treatment Associated Venous Thromboembolism (VTE) and Survival in Multiple Myeloma Patients.

Maurizio Zangari, MD, Federica Cavallo, MD, Louis M. Fink, MD, Bart Barlogie, MD, PhD, Vanessa Bolejack, BS, Michael J. Burns, Elias Anaissie, MD, Klaus A. Hollmig, MD, Abid Mohiuddin, MD, Mauricio Pineda-Roman, MD, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3573.
https://doi.org/10.1182/blood.V108.11.3573.3573
Published: 2006
Journal Articles

S0204: Melphalan (MEL)-Based Tandem Autotransplants (TAT) for Multiple Myeloma (MM) with Thalidomide/Dexamethasone (TD) Induction and Thalidomide/Prednisone (TP) Maintenance: A Phase II Trial of the Southwest Oncology Group.

Mohamad A. Hussein, MD, Andrzej J. Jakubowiak, MD, PhD, Vanessa Bolejack, MPH, Jeff Zonder, MD, John Crowley, PhD, Bart Barlogie
Journal: Blood
Blood (2006) 108 (11): 3088.
https://doi.org/10.1182/blood.V108.11.3088.3088
Published: 2006
Journal Articles

Velcade (V)-Thalidomide (T)-Dexamethasone (D) for Advanced and Refractory Multiple Myeloma (MM): Long-Term Follow-Up of Phase I–II Trial UARK 2001-37: Superior Outcome in Patients with Normal Cytogenetics and No Prior T.

Maurizio Zangari, MD, Bart Barlogie, MD, PhD, Michael J. Burns, BS, BA, Vanessa Bolejack, MPH, Klaus A. Hollmig, MD, Frits van Rhee, MD, PhD, Mauricio Pineda-Roman, MD, Francesca Elice, MD, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2552.
https://doi.org/10.1182/blood.V106.11.2552.2552
Published: 2005